- Language: English
- 228 Pages
- Published: February 2013
Disease and Therapy Review: Epilepsy
- ID: 463736
- July 2013
- Region: Global
- 14 Pages
- Timely Data Resources, Inc
The Epilepsy Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the epilepsy market, as well as sales of leading drugs and therapies are provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the author's senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.
The reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.
The data contained in these reports comes from key industry secondary data sources, such as the authors Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
General description of the condition
Types of seizures
II. INCIDENCE AND PREVALENCE
Incidence Table (US, Scotland, UK, Japan, Turkey, Low/Medium Income Countries, High Income Countries, Developed Countries, Less-Developed Countries, Worldwide) Prevalence Table (Canada, US, Colombia, Mexico, England, France, Germany, Scotland, UK, China, India, Japan, South Korea, Taiwan, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Less-Developed Countries, Worldwide)
Vagus Nerve Stimulation
V. DOSING AND TREATMENT COSTS
Dosing for commonly prescribed drugs
Costs for commonly prescribed drugs
VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals